/4596.T
4596.T Stock - Kubota Pharmaceutical Holdings Co., Ltd.
Healthcare|BiotechnologyJPX
$42.00-2.33%
$1.00 (-2.33%) • Dec 24
57
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.11
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $46.20
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for 4596.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$41.58 – $42.42
TARGET (TP)$48.30
STOP LOSS$38.64
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.43
52W High$144.00
52W Low$38.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $27.19M | $39.89M | $8.25M | N/A | $37.79M |
| Gross Profit | $-521,803,000 | $-59,046,000 | $-56,541,000 | $-59,238,000 | $37.79M |
| Gross Margin | -1919.2% | -148.0% | -685.0% | N/A | 100.0% |
| Operating Income | $-1,232,318,000 | $-1,393,511,000 | $-2,111,726,000 | $-2,644,579,000 | $-2,484,044,000 |
| Net Income | $-1,332,852,000 | $-1,489,602,000 | $-2,015,906,000 | $-2,616,451,000 | $-2,437,424,000 |
| Net Margin | -4902.2% | -3734.6% | -24423.4% | N/A | -6450.6% |
| EPS | $-23.65 | $-26.79 | $-40.92 | $-57.46 | $-56.90 |
Company Overview
Kubota Pharmaceutical Holdings Co., Ltd. develops portfolio of drugs and devices worldwide. Its product pipeline comprises emixustat hydrochloride, which is in Phase III clinical stage used for the treatment of stargardt disease, and Phase II clinical stage used for the treatment of proliferative diabetic retinopathy. The company is also developing remote retinal monitoring device patient-based ophthalmology suite, that includes home-based miniature and NASA high-res version optical coherence tomography devices; and wearable device for myopia control. The company was founded in 2002 and is based in Tokyo, Japan.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
4596.TBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$0.21
Q4 2025
EPS Surprise History
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 14, 2025 | — | $0.21 | — | — |
Q2 2025 | May 14, 2025 | — | $-4.49 | — | — |
Q1 2025 | Feb 14, 2025 | — | $-5.89 | — | — |
Q4 2024 | Nov 14, 2024 | — | $-5.87 | — | — |
Q3 2024 | Aug 14, 2024 | — | $-5.80 | — | — |
Q2 2024 | May 14, 2024 | — | $-6.10 | — | — |
Q1 2024 | Feb 14, 2024 | — | $-6.28 | — | — |
Q4 2023 | Nov 14, 2023 | — | $-5.06 | — | — |
Q3 2023 | Aug 10, 2023 | — | $-5.40 | — | — |
Q2 2023 | May 12, 2023 | — | $-8.09 | — | — |
Q1 2023 | Feb 14, 2023 | — | $-6.23 | — | — |
Q4 2022 | Nov 11, 2022 | — | $-9.44 | — | — |
Q3 2022 | Aug 12, 2022 | — | $-11.73 | — | — |
Q2 2022 | May 13, 2022 | — | $-14.30 | — | — |
Q1 2022 | Feb 14, 2022 | — | $-14.96 | — | — |
Q4 2021 | Nov 12, 2021 | — | $-12.65 | — | — |
Q3 2021 | Aug 12, 2021 | — | $-14.39 | — | — |
Q2 2021 | May 13, 2021 | — | $-15.48 | — | — |
Q1 2021 | Feb 12, 2021 | — | $-12.84 | — | — |
Q4 2020 | Nov 13, 2020 | — | $-14.48 | — | — |
Latest News
Loading news...
Frequently Asked Questions about 4596.T
What is 4596.T's current stock price?
Kubota Pharmaceutical Holdings Co., Ltd. (4596.T) is currently trading at $42.00 per share. The stock has moved -2.33% today.
What is the analyst price target for 4596.T?
No analyst price targets are currently available for this stock.
What sector is Kubota Pharmaceutical Holdings Co., Ltd. in?
Kubota Pharmaceutical Holdings Co., Ltd. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the JPX exchange.
What is 4596.T's market cap?
Kubota Pharmaceutical Holdings Co., Ltd. has a market capitalization of $2.53 billion, making it a mid-cap company.
Does 4596.T pay dividends?
No, Kubota Pharmaceutical Holdings Co., Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare Sector2342.T
Trans Genic Inc.
$254.00
Mkt Cap: $4.2B
4572.T
Carna Biosciences, Inc.
$415.00
Mkt Cap: $7.9B
4576.T
D. Western Therapeutics Institute, Inc.
$93.00
Mkt Cap: $4.1B
4591.T
Ribomic Inc.
$74.00
Mkt Cap: $3.5B
4598.T
Delta-Fly Pharma, Inc.
$500.00
Mkt Cap: $5.7B
4881.T
FunPep Company Limited
$77.00
Mkt Cap: $3.1B
4884.T
Kringle Pharma, Inc.
$378.00
Mkt Cap: $2.6B
6034.T
MRT Inc.
$622.00
Mkt Cap: $3.5B
7782.T
Sincere Co., Ltd.
$538.00
Mkt Cap: $3.5B
9776.T
Sapporo Clinical Laboratory Inc.
$1966.00
Mkt Cap: $6.1B
Explore stocks similar to 4596.T for comparison